Genetic Predisposition
93
28
34
35
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
4 terminated out of 93 trials
89.7%
+3.2% vs benchmark
3%
3 trials in Phase 3/4
17%
6 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (93)
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Vascular Disease Discovery Protocol
Care Plans for Cancer Predisposition
Pancreatic Cancer Early Detection Consortium
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon
Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx Paraganglioma
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
Outcomes of Health Care Transition for AYA With a Cancer Predisposition
COsegregation of VARiants in Panel of Genes
The Preventive Risk Outreach And Cascade Testing
Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes
Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition
COMT Activity and Hypnotizability
Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
Mayo Clinic Precure - Prospective Study
Growing Up in Singapore Towards Healthy Outcomes
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans